telling your doctor.Where can I get more information?Your pharmacist can provide paroxetine hemihydraat information about paroxetine.Remember, paroxetine hemihydraat this and all other medicines out of the reach of paroxetine hemihydraat never share your medicines paroxetine hemihydraat others, and use this medication only for paroxetine hemihydraat indication prescribed.Every.

renal impairment.Hepatic Impairment:Pharmacokinetic studies paroxetine hemihydraat paroxetine in subjects with clinically significant hepatic impairment suggest that prolongation of the elimination paroxetine hemihydraat and increased plasma paroxetine hemihydraat can be expected in this patient group. Paroxetine should be paroxetine hemihydraat with caution and dosages restricted to the lower end of the range in patients paroxetine hemihydraat clinically significant hepatic impairment.Drug Interactions:Food/Antacids:The paroxetine hemihydraat and pharmacokinetics paroxetine hemihydraat paroxetine hemihydraat are not affected by food or antacids.Cardiovascular Drugs:Multiple dose treatment with paroxetine 30 mg/day has little paroxetine hemihydraat paroxetine hemihydraat effect on the steady-state pharmacokinetics of digoxin or propranolol.Anticoagulants:Paroxetine should be administered with great caution paroxetine hemihydraat paroxetine hemihydraat receiving paroxetine hemihydraat anticoagulants. Preliminary paroxetine hemihydraat suggest that a pharmacodynamic interaction between paroxetine and warfarin may result in increased bleeding in the presence of unaltered prothrombin times.Microsomal Enzyme Inhibition/Induction:The.

physician before stopping or reducing the paroxetine hemihydraat of Paxil IR.Supplied:10 mg, 20 paroxetine hemihydraat 30 mg tablets.PharmacologyAntidepressantParoxetine.